Cancer immunotherapy Car T Cell Technology

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to match cancer by changing them in the lab so they can find and end cancer cells. T-cell transfer therapy is a type of immunotherapy that makes your own immune cells better able towards attack cancer. CAR T-cell therapy proved to be more effective than the standard treatment for patients with Non-Hodgkin lymphoma whose cancer repaid after their initial, or first-line, chemotherapy.

There are four types of Car T Cell Therapy:

• B-cell lymphoma (DLBCL)

• Follicular lymphoma

• Mntle cell lymphoma

• Multiple myeloma

• B-cell acute lymphoblastic leukemia (ALL)

Related Tags: Molecular analysis for precision oncology congress 2023, International oncology conference 2022, Oncology 2022, Cancer Immunology and Immunotherapy conference, AIDS 2022 profile, Cancer immunotherapy Car T Cell Technology Conference 2022, Cancer immunotherapy Car T Cell Technology Conference 2023, Cancer immunotherapy Car T Cell Technology Congress 2022, Cancer immunotherapy Car T Cell Technology Congress 2023, European Congress on Cancer immunotherapy Car T Cell Technology 2022

Related Associations: Cancer Patient Resources - Cancer Research Institute (CRI), Gynecologic Oncology, Lustgarten Foundation: Pancreatic Cancer Research, Cancer Organizations, Cancer Society